Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma. Issue 2 (February 2023)
- Record Type:
- Journal Article
- Title:
- Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma. Issue 2 (February 2023)
- Main Title:
- Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma
- Authors:
- Lima, Henrique A.
Alaimo, Laura
Brown, Zachary J.
Endo, Yutaka
Moazzam, Zorays
Tsilimigras, Diamantis I.
Shaikh, Chanza
Resende, Vivian
Guglielmi, Alfredo
Ratti, Francesca
Aldrighetti, Luca
Marques, Hugo P.
Soubrane, Olivier
Lam, Vincent
Poultsides, George A.
Popescu, Irinel
Alexandrescu, Sorin
Martel, Guillaume
Hugh, Tom
Endo, Itaru
Shen, Feng
Pawlik, Timothy M. - Abstract:
- Abstract: Background: Defining patterns and risk of recurrence can help inform surveillance strategies and patient counselling. We sought to characterize peak hazard rates (pHR) and peak time of recurrence among patients who underwent resection of hepatocellular carcinoma (HCC). Methods: 1434 patients who underwent curative-intent resection of HCC were identified from a multi-institutional database. Hazard, patterns, and peak rates of recurrence were characterized. Results: The overall hazard of recurrence peaked at 2.4 months (pHR: 0.0384), yet varied markedly. The incidence of recurrence increased with Barcelona Clinic Liver Cancer (BCLC) stage 0 (29%), A (54%), and B (64%). While the hazard function curve for BCLC 0 patients was relatively flat (pHR: <0.0177), BCLC A patients recurred with a peak at 2.4 months (pHR: 0.0365). Patients with BCLC B had a bimodal recurrence with a peak rate at 4.2 months (pHR: 0.0565) and another at 22.8 months. The incidence of recurrence also varied according to AFP level (≤400 ng/mL: 52.6% vs. >400 ng/mL: 36.3%) and Tumor Burden Score (low: 73.7% vs. medium: 50.6% vs. high: 24.2%) (both p < 0.001). Conclusion: Recurrence hazard rates for HCC varied substantially relative to both time and intensity/peak rates. TBS and AFP markedly impacted patterns of hazard risk of recurrence.
- Is Part Of:
- HPB. Volume 25:Issue 2(2023)
- Journal:
- HPB
- Issue:
- Volume 25:Issue 2(2023)
- Issue Display:
- Volume 25, Issue 2 (2023)
- Year:
- 2023
- Volume:
- 25
- Issue:
- 2
- Issue Sort Value:
- 2023-0025-0002-0000
- Page Start:
- 260
- Page End:
- 268
- Publication Date:
- 2023-02
- Subjects:
- Liver -- Diseases -- Periodicals
Biliary tract -- Diseases -- Periodicals
Pancreas -- Diseases -- Periodicals
616.362005 - Journal URLs:
- https://www.journals.elsevier.com/hpb/ ↗
http://www.hpbonline.org/current ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1477-2574 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1016/j.hpb.2022.11.008 ↗
- Languages:
- English
- ISSNs:
- 1365-182X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4335.262340
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 25966.xml